The chemical-biological interface: Developments in automated and miniaturised screening technology

Current Opinion in Biotechnology

Volumn 8, Issue 6, 1997, Pages 734-740

  Houston, John G ^a   Banks, Martyn ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; BIOASSAY; GENOME; PRIORITY JOURNAL; REVIEW; ROBOTICS; SCREENING TEST;

EID: 0030666868     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(97)80128-0     Document Type: Article

References (55)

1. Drews J, Ryser S. Pharmaceutical innovation between scientific opportunities and economic constraints. Drug Discov Today. 2:1997;365-372.
2. Drews J. Strategic choices facing the pharmaceutical industry a case for innovation. Drug Dis Today. 2:1997;72-78.
3. Cimarusti CM. Project acceleration - the case for quantum change. Drug Discov Today. 2:1997;1.
4. Warr WA. Combinatorial chemistry and molecular diversity. An overview. J Chem Int Comput Sci. 37:1997;134-140.
5. Hardin JH, Smietana FR. Automating combinatorial chemistry: challenges and pitfalls. Devlin JP. High Throughput Screening: The Discovery of Bioactive Substances. 1997;251-261 Marcel Decker, New York.
6. Reichman M, Marples E, Lenz S. Approaches to automation for high-throughput screening. Lab Rob Autom. 8:1996;267-276.
7. Hook DJ. Team building and leadership in the successful implementation of automation for high throughput screening. of special interest J Auto Chem. 18:1996;134-134 The diverse mix of skills and technical needed to run an efficient high-throughput screening programme is essential.
8. Babiak J. Management and service issues of a centralized robotic HTS core. of special interest Devlin JP. High Throughput Screening: The Discovery of Bioactive Substances. 1997;461-470 Marcel Dekker, New York, Good overview of issues in managing a core high throughout screening robotic group.
9. Beggs M, Major JS. Flexible use of people and machines. Devlin JP. High Throughput Screening: The Discovery of Bioactive Substances. 1997;471-481 Marcel Dekker, New York.
10. Bojanic D, Keighley WW, Russell MJ, Wood TP. Factors for the successful integration of assays, equipment, robotics and software. of special interest Devlin JP. High Throughput Screening the Discovery of Bioactive Substances. 1997;493-508 Marcel Dekker, New York, This chapter gives a detailed description of the high-throughput screening process. This involves compound supply, assay considerations, data capture, data analysis and progression of compounds which come up positive in the screen. This is one of the rare insights into a large pharmaceutical company's high-throughput screening process.
11. Woo J, Henry JB. The advance of technology as a prelude to the laboratory of the twenty-first century. Clin Lab Med. 14:1994;459-471.
12. Janzen WP. High throughput screening as a discovery tool in the pharmaceutical industry. of special interest Lab Rob Autom. 8:1996;261-265 Overview of high-throughput screening process with particular reference to Eli Liley and Co. organisation and screening paradigm. High-throughput screening capacity has been increased 100-fold over four years, 4-fold from automation applications and 25-fold from process improvements.
13. Houston JG. Drug discovery turning serendipity into certainty. Prescriber. 7:1996;57-61.
14. Goldman M. High throughput screening: drug discovery through automation. Pharmaceutical News. 2:1995;23-25.
15. Harding D, Banks M, Fogarty S, Binnie A. Development of an automated high-throughput screening system: a case history. of special interest Drug Discov Today. 2:1997;385-390 This paper describes how a large high-throughput robotic system was designed, built and commissioned. It details the specification of the robotic system and describes the final design. This will be especially useful for individuals considering investing in these types of systems to give an insight into the procurement process.
16. Banks M, Binnie A, Fogarty SJ. High throughput screening using fully integrated robotic screening. J Biomol Screening. 2:1997;133-135.
17. Babiak J. Transforming your robotics into an infrastructure for the future. J Biol Screening. 2:1997;139-143.
18. Fogarty S, Mellor G, Banks MN, Mills K, O'Brien S, Jeffries B, Houston JG. Automation of scintillation proximity assay (SPA) high throughput screening on the robolab 9600. Amersham Proximity News. 29:1996;1-6.
19. Lutz MW, Menius JA, Choi TD, Gooding-Laskody R, Domanico PL, Goetz AS, Saussy DL. Experimental design for high-throughput screening. Drug Discov Today. 1:1996;277-286.
20. McCaffrey C, Powers G, Talbot MK. Utilization of the ORCA to completely automate scintillation proximity assays. J Biomol Screening. 1:1996;187-190.
21. Mellor GW, Forgary SJ, O'Brien MS, Congreve M, Banks MN, Mills KM, Jeffries B, Houston JG. Searching for chemokine receptor binding antagonists by high throughput screening. J Biomol Screening. 2:1997;153-157.
22. Sarubbi E, Yandofsky SD, Barrett RW, Denaro M. A cell-free, nonisotopic, high throughput assay for inhibitors for type 1 interleukin-1 receptor. Anal Biochem. 237:1996;70-75.
23. Rice JW, Davis JE, Crowl RM, Johnston PA. Development of a high volume screen to identify inhibitors of endothelial cell activation. Anal Biochem. 241:1996;254-259.
24. Singh J, Soloweij, Allen M, Killar L, Ator M. Lead development: validation and application of high throughput screening of pharmacokinetic parameters for enzyme inhibitors. Bioorg Med Chem. 4:1996;639-643.
25. Kolb JM, Yamanaka G, Manly SP. Use of a novel homogeneous fluorescent technology in high throughput screening assays. of special interest J Biomol Screening. 1:1996;203-210 Example of the application of automation and new assay technologies, specifically homogeneous time-resolved fluorescence. The authors also describe the effect of screening synthetic compounds and natural products using this technique.
26. Broach JR, Thorner J. High throughput screening for drug discovery. Nature. 384:1996;14-16. (suppl).
27. Suto CM, Ignar DM. Selection of an optimal reporter gene for cell-based high throughput screening assays. J Biomol Screening. 2:1997;7-9.
28. Wallace RW, Goldman ME. Bioassay design and implementation. of special interest Devlin JP. High Throughput Screening: The Discovery of Bioactive Substances. 1997;279-305 Marcel Dekker, New York, Overview of assay design approaches for biochemical and cellular high-throughput screening.
29. Schullek JR, Butler JH, Ni Z-J, Chem D, Yuan Z. A high density screening format for encoded combinational libraries: assay miniaturisation and its application to enzymatic reactions. of outstanding interest Anal Biochem. 246:1997;20-29 A good example of convergence between high-throughput screening and combinatorial chemistry. With the description of a novel miniaturised high-throughput screening format for libraries on beads utilising photolytic cleavage of individual compounds into small volume high density assays.
30. Gordon EM, Barrett RW, Dower WJ, Fodor SPA, Gallop M. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies and future directions. J Med Chem. 37:1994;1385-1401.
31. Hogan JC. Directed combinatorial chemistry. Nature. 384:1996;17-19. (suppl).
32. Kris RM, Wilson P, Josiah S, Wildgoose M, Yeoman H, Krchnuk V, Baum S, Pelder S. Combichem high throughput screening for leads optimization. Devlin JP. High Throughput Screening: The Discovery of Bioactive Substances. 1997;263-271 Marcel Dekker, New York.
33. Geyson HM, Meleon RH, Barteling SJ. Use of peptide synthesis to probe-viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci USA. 81:1984;3998-4002.
34. Houghten RA. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level at individual amino acids. Proc Natl Acad Sci USA. 82:1985;5131-5135.
35. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature. 354:1991;84-86.
36. Needels MC, Jones DG, Tate EH, Heinkel GL, Kochersperger LM, Dower WJ, Barrett RW, Gallop MA. Generation and screening of an oligonucleotide - encoded synthetic peptide library. Proc Natl Acad Sci USA. 90:1993;10700-10704.
37. Civita S, Peters EA, Barrett RW, Dower WJ. Peptides on phage in a vast library of peptides for identifying ligands. Science. 228:1985;1315-1317.
38. Baldwin JJ. Design, synthesis and use of binary encoded synthetic chemical libraries. Mol Diversity. 2:1996;81-88.
39. Cargill JF, Maiefski RR, Toyonaga BE. Automated combinational chemistry on solid phase. Proc Int Symp Lab Autom Robotics. 1995;221-234.
40. Lemmo AV, Fisher JJ, Geyson HM, Rose DJ. Characterisation of an inkjet chemical microdispenser for cominatorial library synthesis. of special interest Anal Chem. 69:1997;543-551 A characterisatoin of solenoid values for dispensing chemical reagents and their incorporation in an automated chemical inkjet printer for use in parallel high density combinatorial chemical synthesis.
41. Evans DM, Williams KP, McGuiness B, Tarr G, Regriver F, Afegan N, Jindal S. Affinity-based screening of combinatorial libraries using automated, serial-column chromatography. Nat Biotechnol. 14:1996;504-507.
42. Hook D. Ultra high throughput screening - a journey into Nanoland with Gulliver and Alice. Drug Discov Today. 7:1996;267-268.
43. Kolb AJ, Neumann K. Beyond the 96-well plate: instruments and assay methods for 384-well format. J Biomol Screening. 2:1997;103-109.
44. Rogers M. High throughput screening: liquid handling systems for 384 well application. Drug Discov Today. 2:1997;395-396.
45. Janzen B, Domanico P. The 384-well plate: pros and cons. J Biomol Screening. 1:1996;63-64.
46. Comley JNW, Binnie A, Bonk C, Houston JG. A 384-HTS for human factor Vlla: comparison with 96 and 864 well formats. of special interest J Biomol Screening. 2:1997;171-178 They discuss the experiences with assay development, liquid handling using a Tomtec Quadra™ and Matrix PlateMate™ and screening of 200,000 compounds against factor Vlla in a 384-well plate format. The authors also describe the results of a comparison between 96-, 384- and 864-well plates in total assay volumes of 100, 25 and 10 μl, respectively.
47. Brecht A, Burckardt R, Rickert J, Stemmler I, Schuetz A, Fischer S, Friedrich T, Gauglitz G, Goepel W. Transducer-based approaches for parallel binding assays in HTS. J Biomol Screening. 1:1996;191-201.
48. Weiss-Wichert CH, Smetazko M, Valina-Saba M, Schalkhammer TH. A new analytical device based on gated ion channels: a peptide-channel biosensor. J Biomol Screening. 2:1997;11-18.
49. Cornell BA, Braach-Maksvytis VLB, King LG, Osman PDJ, Raguse B, Wieczorek L, Pace RJ. A biosensor that uses ion-channel switches. of special interest Nature. 387:1997;580-583 Describes a novel biosensor using gramicidin lipid layers to create an ion channel. This was used to construct an immunoassay. This biochemical-based transducer system has potential uses in a whole range of in vitro assays as well as the immunoassay described. Furthermore, this technique, it developed further, is one possible solution for miniaturised high-throughput screening system.
50. Gopel W. Ultimate limits in the miniaturization of chemical sensors. Sensors and Actuators. 456:1996;83-102.
51. Hemmila I, Webb S. Time-resolved fluorometry, an overview of the labels and core technologies for drug screening applications. Drug Discov Today. 2:1997;373-381.
52. Sterrer S, Henco K. Fluorescence correlation spectroscopy (FCS) - a highly sensitive method to analyse drug/target interactions. J Recept Signal Transduct Res. 17:1997;511-520.
53. Jolley ME. Fluorescence polarization for the detection of proteases and their inhibitors. J Biomol Screening. 1:1996;33-38.
54. Armstrong JW, Tipsword M, Sampson W, Thomason A, Hamilton SD. Automated high throughput RT-PCR. Lab Robotics Autom. 8:1996;311-315.
55. Dario P, Valleggi R, Carrozza MC, Montesi MC, Cocco M. Miniatured and microbotics: technologies and applications. Gray JO, Caldwell DG. Advanced Robotics and Intelligent Machines. 1996;271-279 Inspec/IEE, Stevenage.